January 03, 2019
Rose
James Carroll has led the Office of National Drug Control Policy in an acting capacity since February. The Senate also confirmed Kelvin Droegemeier to head up the White House’s Office of Science and Technology, giving the office a director for the first time since President Donald Trump's inauguration.
from Kaiser Health News http://bit.ly/2Asq3Jg
January 03, 2019
Rose
Health News, Kaiser Health News
No comments
Senate Confirms ‘Drug Czar’ To Lead Office In Charge Of Administration’s Response To Opioid Epidemic
Related Posts:
Practices With High-Risk Populations Lagging Behind On Medicare’s Annual Wellness Visits- FDA Sharpens Stance Against Herbal Supplement Kratom: ‘It Isn’t Just A Plant — It’s An Opioid’
- CMS Chief Pledges To Bring A Rural Health Lens To All Agency Policies
- How Hospital Nonprofits Structure Themselves Helps Determine How Hard They’re Hit By New Tax Rules
- ‘Right To Try’ Legislation Will Do More Harm Than Good, Patient Advocacy Groups Warn Congress
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment